First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence.
As of June 1998, four randomized trials have been completed comparing the combination of paclitaxel and cisplatin with a cisplatin-based control arm. The results of three of these trials are available; one has been published as a full paper, the other two in abstract form only. Two of the reported t...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group|1
1998
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063206/ |